Biocept
BIOC
$0.43
Share price
0.00%
Change (1 day)
-95.74%
Change (1 year)
Categories
Biocept (BIOC) - P/B ratio
P/B ratio as of May 2024 : 3.94
According to Biocept
's latest financial reports the company has a price-to-book ratio of 3.94.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Biocept - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.94 | 285.92% |
| 2022-12-31 | 1.02 | -37.27% |
| 2021-12-31 | 1.63 | -35.21% |
| 2020-12-31 | 2.51 | 79.62% |
| 2019-12-31 | 1.40 | 6.81% |
| 2018-12-31 | 1.31 | -93.05% |
| 2017-12-31 | 18.8 | -8.51% |
| 2016-12-31 | 20.6 | 180.11% |
| 2015-12-31 | 7.35 | -114.69% |
| 2014-12-31 | -50.0 | |
| 2013-12-31 | N/A | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | 1.47 | -62.57% | 🇺🇸 USA |
 Exact Sciences EXAS | 3.51 | -10.93% | 🇺🇸 USA |
 Myriad Genetics MYGN | 2.25 | -42.89% | 🇺🇸 USA |